+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
534920 ISERA

iSERA Lifesciences Share Price

 
Stock touched ten year high

 

iSERA Lifesciences live price: ₹124.17. It opened at ₹124 vs previous close ₹122; intraday high/low: ₹124/₹124. The 50 & 200 DMA stand at ₹83.82/₹43.95.

iSERA Lifesciences Performance

  • Today's Low
  • ₹124
  • Today's High
  • ₹124
  • 52 Week Low
  • ₹2
  • 52 Week High
  • ₹124
  • Open Price₹124
  • Previous Close₹122
  • Volume11
  • 50 DMA₹83.82
  • 100 DMA₹64.40
  • 200 DMA₹43.95

iSERA Lifesciences Chart

Investment Returns

  • Over 1 Month + 60.24%
  • Over 3 Month + 138.83%
  • Over 6 Month + 690.89%
  • Over 1 Year + 4731.52%

Smart Investing Starts Here Start SIP with iSERA Lifesciences for Steady Growth!

Invest Now

iSERA Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 402.5
  • PEG Ratio
  • 4.6
  • Market Cap Cr
  • 104
  • P/B Ratio
  • 12.7
  • Average True Range
  • 1.88
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 10.28
  • RSI
  • 100
  • MFI
  • 100

iSERA Lifesciences Financials

iSERA Lifesciences Technicals

EMA & SMA

Current Price
₹124.17
+ 2.43 (2%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹102.50
  • 50 Day
  • ₹83.80
  • 100 Day
  • ₹64.40
  • 200 Day
  • ₹44.00

Resistance and Support

121.74 Pivot Speed
  • R3 121.75
  • R2 121.75
  • R1 121.74
  • S1 121.73
  • S2 121.73
  • S3 121.72

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

iSERA LIFESCIENCES LTD has an operating revenue of Rs. 2.37 Cr. on a trailing 12-month basis. An annual revenue growth of 430% is outstanding, Pre-tax margin of 25% is great, ROE of 3% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 99 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 175 indicates it belongs to a poor industry group of Computer-Tech Services and a Master Score of D is close to being the worst. Overall, the stock has some relative strength and buyer demand but we want to see further fundamental performance to qualify as a growth stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

iSERA Lifesciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-21 Audited Results
2026-04-20 Preferential issue of shares
2026-02-10 Quarterly Results
2025-11-13 Quarterly Results
2025-10-09 Rights issue of Equity Shares

iSERA Lifesciences Shareholding Pattern

58.63%
0%
0%
0%
0%
35.7%
5.67%

iSERA Lifesciences FAQs

iSERA Lifesciences share price is ₹124 As on 25 June, 2026 | 12:57

The Market Cap of iSERA Lifesciences is ₹104.4 Cr As on 25 June, 2026 | 12:57

The P/E ratio of iSERA Lifesciences is 402.5 As on 25 June, 2026 | 12:57

The PB ratio of iSERA Lifesciences is 12.7 As on 25 June, 2026 | 12:57

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23